Elixir Pharmaceuticals Company
Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company's scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.
Total Funding:
$98.5M
Headquarters:
United States
Funding Status:
Late Stage Venture
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Last Funding Type:
Series D
Number Of Exists:
Series D
Technology:
Geroscience
Investor Type:
Company
Investors Number:
9
Founded Date:
1999-01-01
Industry:
Others